New 2-amino-thiazole-4-acetamides with antiplatelet activity.

Arch Pharm (Weinheim)

Institut für Pharmazie, Freie Universität Berlin, Berlin, Germany.

Published: October 2008

In the Born test, 23 title compounds were synthesized and investigated for their antiplatelet activities against collagen, ADP, adrenaline, and platelet-activating factor (PAF) as inducers of the aggregation. Using collagen, three compounds with IC(50) values below 10 microM were found (3a, 3b, 3c) and 15 compounds with IC(50) values between 10 and 100 microM were determined. In general, a cyclohexylamino rest on an 4-carboxamide moiety is a pre-requisite for this pharmacological activity. A clear dependence from the substituent R(1) in the structural element Y is observed. The same is true for the spacer n in the 4-carboxamide substituent. Compound 3e showed strong ADP-antagonistic effects (IC(50) = 2.2 nM); 3c antagonized adrenaline (IC(50) = 2.8 nM), while 3n was highly effective against platelet-activating factor (IC(50) = 0.2 microM).

Download full-text PDF

Source
http://dx.doi.org/10.1002/ardp.200700046DOI Listing

Publication Analysis

Top Keywords

platelet-activating factor
8
compounds ic50
8
ic50 values
8
ic50
5
2-amino-thiazole-4-acetamides antiplatelet
4
antiplatelet activity
4
activity born
4
born test
4
test title
4
title compounds
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!